Unique ID issued by UMIN | UMIN000024376 |
---|---|
Receipt number | R000028064 |
Scientific Title | Sublingual immunotherapy using imported birch pollen extract for injection |
Date of disclosure of the study information | 2016/12/01 |
Last modified on | 2019/04/17 10:37:03 |
Sublingual immunotherapy using imported birch pollen extract for injection
Sublingual immunotherapy using imported birch pollen extract for injection
Sublingual immunotherapy using imported birch pollen extract for injection
Sublingual immunotherapy using imported birch pollen extract for injection
Japan |
oral allergy syndrome (OAS)
Clinical immunology |
Others
NO
To examine the effectiveness of sublingual immunotherapy using birch pollen extract for oral allergy syndrome (OAS)
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
The primary outcome is the change in OAS symptoms after the treatment, which is evaluated by oral food challenge test with numerical rating scale (NRS) before and at some time points after the treatment.
We also measure nonspecific IgE, specific IgE and specific IgG4 to birch pollen and causative foods before and after the treatment.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Because there is no allergen extract of birch pollen approved for use in therapy at the moment in Japan, we use Birch Mix for injection made by ALK-Abello (USA). We have obtained certification from the ethical committee.
Patients hold the drops of the extract sublingually for 2 minutes, and then swallow them, refraining from gargling, drinking and eating for another 5 minutes. Patients are monitored precisely for 30 minutes after ingestion of the extract.
This maneuver is started in hospital with rush method. The starting dose is principally 0.1ml of 100-fold dilution of original extract (1:20), and the maneuver is repeated 4 times a day increasing the dose every time possibly up to 0.1ml of original extract.
After then, the maneuver is continued at home once daily.
Not applicable |
Not applicable |
Male and Female
Persons who have been sensitized with birch pollen (specific IgE>0.7 UA/mL, ImmunoCAP) and suffer from OAS symptoms by ingestion of fruits or vegetables.
Severe immune abnormality or immunodeficiency, malignancy, severe mental disorder, use of beta blocker, poor compliance, uncontrolled asthma, use of cardiovascular drugs increasing a side effect of the adrenaline, pregnancy, etc..
10
1st name | Kazuyuki |
Middle name | |
Last name | Kurihara |
Kanagawa Children's Medical Center
Department of Allergy
2328555
2-138-4, Mutsukawa, Minami-ku, Yokohama-shi, Kanagawa
045-711-2351
kkurihara@msb.biglobe.ne.jp
1st name | Shuntaro |
Middle name | |
Last name | Tsumagari |
Kanagawa Children's Medical Center
Department of Allergy
2328555
2-138-4, Mutsukawa, Minami-ku, Yokohama-shi, Kanagawa
045-711-2351
stsumagari@kcmc.jp
Kanagawa Children's Medical Center Department of Allergy
Kanagawa Children's Medical Center
Self funding
Research ethics committee, Kanagawa Children's Medical Center
2-138-4, Mutsukawa, Minami-ku, Yokohama-shi, Kanagawa
0457112351
kcmcrinri@kanagawa-pho.jp
NO
神奈川県立こども医療センター(神奈川県)
2016 | Year | 12 | Month | 01 | Day |
Unpublished
1
Completed
2016 | Year | 01 | Month | 31 | Day |
2016 | Year | 02 | Month | 05 | Day |
2016 | Year | 12 | Month | 01 | Day |
2019 | Year | 03 | Month | 31 | Day |
2016 | Year | 10 | Month | 12 | Day |
2019 | Year | 04 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028064